Department of Medicine, University of Florida College of Medicine, 1600 SW Archer Road, Gainesville, FL 32610-0278, USA.
Biol Blood Marrow Transplant. 2010 Dec;16(12):1682-92. doi: 10.1016/j.bbmt.2010.05.017. Epub 2010 Jun 1.
Hematopoietic cell transplantation (HCT) is an intensive treatment for hematologic malignancies that has the potential to cure disease or prolong life, but also to impair quality of life for survivors. Earlier studies have suggested that various factors are associated with physical and mental health after HCT. In this study, we evaluated demographic and clinical factors before and after HCT and selected psychosocial factors after HCT, exploring their association with self-reported physical and mental health. We studied a cohort of 662 survivors at a median of 6.6 years after HCT. Pre-HCT demographic and clinical factors accounted for only a small amount of the variance in physical and mental health post-HCT (3% and 1%, respectively). Adding post-HCT clinical variables to the pre-HCT factors accounted for 32% and 7% of physical and mental outcomes, respectively. When both clinical and psychosocial factors were considered, better physical health post-HCT was associated with younger age, race other than white, higher current family income, currently working or being a student, less severe transplantation experience (ie, not experiencing graft-versus-host disease), fewer current comorbidities, higher Karnofsky status, less social constraint, less social support, and less trait anxiety. This multivariate model accounted for 36% of the variance in physical health, with the psychosocial variables contributing very little. When both clinical and psychosocial factors were considered, better mental health after HCT was associated with more severe transplantation experience, less social constraint, greater spiritual well being, and less trait anxiety. This multivariate model accounted for 56% of the variance in mental health, with the psychosocial factors accounting for most of the variance. These data suggest that clinical factors are explanatory for much of the post-HCT physical health reported by HCT survivors, but very little of self-perceived mental health. These observations provide insight into the identification of factors that can allow recognition of at-risk patients, as well as factors amenable to intervention.
造血细胞移植(HCT)是一种治疗血液系统恶性肿瘤的强化治疗方法,有治愈疾病或延长生命的潜力,但也会损害幸存者的生活质量。早期研究表明,各种因素与 HCT 后身心健康有关。在这项研究中,我们评估了 HCT 前后的人口统计学和临床因素,并选择了 HCT 后的社会心理因素,探讨它们与自我报告的身心健康的关系。我们研究了 662 名 HCT 后中位时间为 6.6 年的幸存者队列。HCT 前的人口统计学和临床因素仅解释了 HCT 后身心健康的一小部分变异(分别为 3%和 1%)。将 HCT 后临床变量添加到 HCT 前因素中,分别占身体和精神结果的 32%和 7%。当同时考虑临床和社会心理因素时,HCT 后身体状况较好与年龄较小、非白种人、当前家庭收入较高、目前工作或上学、移植经历较轻(即无移植物抗宿主病)、当前合并症较少、Karnofsky 状态较高、社会约束较少、社会支持较少、特质焦虑较少有关。这个多变量模型解释了身体健康变化的 36%,社会心理变量的贡献很小。当同时考虑临床和社会心理因素时,HCT 后心理健康较好与移植经历较严重、社会约束较少、精神健康较好和特质焦虑较少有关。这个多变量模型解释了心理健康变化的 56%,社会心理因素占大部分。这些数据表明,临床因素可以解释 HCT 幸存者报告的大部分 HCT 后身体健康,但对自我感知的心理健康影响很小。这些观察结果为确定可以识别高危患者的因素以及可以干预的因素提供了思路。